PPARG and breast cancer: Interestingly, the same authors demonstrated that low doses of both RXR and PPARγ ligands synergistically reduced breast cancer stem cell growth dampening the expression of two NF-kB regulated genes and IL6, thus exerting anti-inflammatory activities [163].